The growing focus on the health and environmental impacts of plastics is a ticking timebomb for corporates using plastics and their investors. One challenge for investors in pricing in this risk is understanding how different corporates are exposed to potential risk from their product portfolios. This lack of transparency creates a blind spot for investors seeking to understand the risk to their portfolio companies.